[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"153c74d1f74d8bb460562d01523b51c58256ff8438a9c29345a681da97ff38b3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"153c74d1f74d8bb460562d01523b51c58256ff8438a9c29345a681da97ff38b3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-03b0bbb9723907cf3d1b41cf0bb34837dc398e42","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"e3c6918fda47581e2f044b07de39270f7d0a73373f6848d8fc53c0d28a6a01e4","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-0837245627eb714ae6bb0375f7abe8f41042011f","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"e3c6918fda47581e2f044b07de39270f7d0a73373f6848d8fc53c0d28a6a01e4","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-08c92e359bbbc110b0778b7e0b15d6f40000e6b1","semester":"1262","observed_at":"2025-08-21 07:05:14.730696+00:00","record_version_id":"93d172572562b3b51275d0761ad069d71b42655c2588ba1a3e14b6f1ac40926e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-0944d76440dc778fbb89626058c10451009ce9c6","semester":"1262","observed_at":"2025-05-21 03:36:18.194118+00:00","record_version_id":"a1c313cde3924b05fe98b742715444ddd782bd7a9cc39f91030b8d572d5854ad","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-0a7f4bce29c816ef4d3d71b4eb8a2a3e15e33cc1","semester":"1262","observed_at":"2025-06-18 20:04:02.695444+00:00","record_version_id":"8d6f7afca372747ba736af4854ac502c2b8d4fd98a466be735cb5a6fab96d7c6","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-0ab917f827a7de22ebdc1087114d377a31c4687b","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"bb0678d85a8d4d7f88c8788e846fb13c009f44bfaa2ed79114402b6e6c3749c7","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-0c40ecab4b6db9333d1f18aef816e3ee659e300c","semester":"1262","observed_at":"2025-05-25 18:02:34.797617+00:00","record_version_id":"9d5ec46115ef8d8b042ed5f53b33e03bcb33625a0742ba874fa71512a5a9ba7e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-0cb4d29a588ec7f11c7e00b7cf5dc3a0d23d0349","semester":"1266","observed_at":"2026-01-22 01:00:26.555427+00:00","record_version_id":"dc7f58107f4c31c3f9d10bee7fd0777b90783537bd57cdb463e1f5288ae0a24b","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-11c30ec39e91498cbfcf3a923c53a4b03e387280","semester":"1262","observed_at":"2025-07-20 04:58:26.847117+00:00","record_version_id":"bd077020674a76d7eda8051baeb7d3d6bcf6dd8d8a7498203f2e19ed07cea43e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-13cd500edf2587e9a3428f326253738fbea965ea","semester":"1264","observed_at":"2025-12-14 04:50:04.653658+00:00","record_version_id":"eaa14f2603dda357b82646527e941cfcd5af0ef0944ac27aca59e9536289b5f7","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-1da08b2de39f05e6bc877c189fc2fd6eeda563f5","semester":"1262","observed_at":"2025-07-01 00:03:56.707251+00:00","record_version_id":"038aa31ba7ee9ac8bde7be0d2dbd02186685f2545f991fdf9cf8cec21a8d7ec8","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-2031af47efe133b0e7877f433286ff07385afc41","semester":"1262","observed_at":"2025-07-02 20:16:45.749584+00:00","record_version_id":"16522a7fc2bfafb04387cfcde8e75993661b9844b3440fec9227ed7a965533ad","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-238eba6f32fbc30407f616dd0628ff02a2a824dd","semester":"1262","observed_at":"2025-08-17 05:15:07.788352+00:00","record_version_id":"4b0aca327863b56f3c12dee29118dd1a3a67440fc75f717ba4ed863c439ac132","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-25f0ff56bc4d80f8a8afa1a0bcce8dae6fddb5e5","semester":"1262","observed_at":"2025-05-25 17:20:25.942090+00:00","record_version_id":"a13cbd4dcfdcef65585b979fbde6e718c8b54bf7de8e2b2469624d40b69cc6f2","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-2923f91826ce253b7aeefa9f75b4a39fe4c80ff0","semester":"1262","observed_at":"2025-08-10 05:10:25.938416+00:00","record_version_id":"293f8e7c62a1a59592b349061315750546f7f852a0fea6eaeab14d8d252e7320","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-2a05214a4023e0157fa6f7d188c85308f714176c","semester":"1262","observed_at":"2025-09-07 04:56:38.255315+00:00","record_version_id":"e6a16302944a7cd0fe188ab76fdd5bbe46ae03133dbf74e998876f91990405b6","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-2b1b8e39131de92b94620b25c5bbb25690efed4c","semester":"1262","observed_at":"2025-06-01 07:54:53.913454+00:00","record_version_id":"88283756541567081c70f24ca8b222c1120a14196a981f2eaf80a69fa8b5c0a1","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-33a1225644e5a5855d60f66e65413946e72fedf4","semester":"1262","observed_at":"2025-06-22 01:52:05.152650+00:00","record_version_id":"e5703735acd0975e31a9679df194e7c773dac4332a741c12a80dfea20190da7e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-3b89c83dbf5208e13756184de1f2b2d0c09af35f","semester":"1262","observed_at":"2025-06-30 06:40:10.235522+00:00","record_version_id":"b93503c5397ce751ae7d243190744906a43f7d43ef19a7697a38308bec2da327","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-3c3eebf7f35c39364b445a2fa5a112ce28dbb4a1","semester":"1262","observed_at":"2025-06-01 17:03:59.062985+00:00","record_version_id":"91f1f6bd3b7b052263eed56f86c3a599e372bea0c667f11cdf7c6ffd58c45680","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-3fa4dd71391f1c9cf4ab2216680bbc428689f92d","semester":"1262","observed_at":"2025-05-25 01:15:58.180530+00:00","record_version_id":"cedb36e3661d9de47fbe592f5fae02887b11c3432ef896417b9e1c533027a7c3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-4040aa216da722a34483f68fc1e129ea571ae08d","semester":"1262","observed_at":"2025-06-01 07:27:39.695506+00:00","record_version_id":"70783a232c70ab6ce48b433a7f0bbb99118f24424c720710e33868cbae323c01","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-454d53cd690294459f8ad0793cc3ed562060e56c","semester":"1262","observed_at":"2025-05-25 01:34:00.536004+00:00","record_version_id":"477ae091611bb45da30d5ae8f317f2850ad6a7364c0c2b392c2dda07ebfbd483","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-486f091e051fdb4ccdb80ee7b4fb0a5814510324","semester":"1264","observed_at":"2025-11-16 05:32:31.273726+00:00","record_version_id":"c7f0f721a3b5fcce231e8354b9c95e3b5236669e46499a84f4d113b020ac20ad","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-50393cfc5fd5598d4f4731ef1919f2ff53af07d9","semester":"1262","observed_at":"2025-06-30 06:05:57.438846+00:00","record_version_id":"98c044bb2ad47493076fe80ec25696fe8298e5433be058e196c7f13e0cce0062","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-50f6947786b208c800db8bbd0cec84a8f0f187d2","semester":"1262","observed_at":"2025-06-02 03:49:42.915428+00:00","record_version_id":"a42f2de9478248a28aefa3a9a446605438670e81abaf24f5a453dd0155cddbf7","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-51d86ed4082dced3803c295419b0ec8440942016","semester":"1264","observed_at":"2025-11-12 04:50:41.141307+00:00","record_version_id":"b96f7cb1b3dae96f2d5ba6cb00d56941743ed46d6e79c6771a344111373f9471","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-53101bd1c10db0d00d094e4c9154d4c244ff23d9","semester":"1262","observed_at":"2025-10-05 04:58:05.366968+00:00","record_version_id":"1b37a582c6088d1b61cf751129ac56e31765e8b6ddea70e3fc40c6b041a003d2","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-58751151c564e11c5cb8aedd3a2d3527c22f73eb","semester":"1262","observed_at":"2025-06-01 06:59:01.536576+00:00","record_version_id":"d2705d0f9efffce49b699c2cc107a975ffc6da0def28482fb4b411217c85ec24","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-5c4c8d3701a333ba4ddadef7d0b5dde8440fcdf0","semester":"1262","observed_at":"2025-06-01 01:57:51.256704+00:00","record_version_id":"2bb340c0167e1bc3d31945587884486bc2b4c6ad72ba9739b74b65b8a351b477","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-5d20d9f81651d3c83fcaa2fd10870ce6e5d5a685","semester":"1262","observed_at":"2025-05-21 16:48:48.484741+00:00","record_version_id":"08186c53aba5d773b94fb1b37099b907a7a35d87f2fec5111d2a0ef18aafaf97","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-5feaebf2ab37051c86ad360cc0fa0d7e0e2ea295","semester":"1262","observed_at":"2025-05-24 15:58:23.378859+00:00","record_version_id":"12a5981c11613721b7a951604c537c7f0272edb9a5528d5bdf9d1255c2514896","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-60949965544fce098cc006354e201149005fb77b","semester":"1264","observed_at":"2025-10-26 05:07:14.077864+00:00","record_version_id":"4358a0e882c64fa4afff26d41da1b22b7aa3a3ac947a03b0fad04570fcd2fb7b","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-639225ac3addf8522f1d30cb4fe26054ea7f8c49","semester":"1262","observed_at":"2025-06-01 08:14:42.497608+00:00","record_version_id":"57ae9dccfcde86078de07d6e0883979979cdc0158f1871b16e68513b82b735c3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-64093b17b3a9c67a41aa33eb37adb53ec38df714","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"02939dbd5436248e07f4dae2cb2bea1ba0a76ca4c30ea568a1b9351e6b5b87a5","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-6885b56099f55e08aa0205546369fb0381d50e13","semester":"1262","observed_at":"2025-07-13 04:59:22.367394+00:00","record_version_id":"a9d1df17772b227b7d33046c074f7808b7c4c02c61b0a4a37d9f53c42e8c1372","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-69d4b2b16e8268f75b6390b3a0e2ce8bf73999da","semester":"1262","observed_at":"2025-06-30 03:21:29.925498+00:00","record_version_id":"435a8d4346742d3f1c01b1770c47e6acfa98285462850dcba9ad3016f052e5b3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-6b29c3e0673b2f9a736d2363db5409e03d5b3ed4","semester":"1264","observed_at":"2025-12-03 12:33:41.418072+00:00","record_version_id":"0cdf6246deed0ee5ceb6659ef0339c8c13f421c96736d9fcaccd2cedd1785a29","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-73259984748de484976ef2ad56ad7ab3d4cb4518","semester":"1262","observed_at":"2025-06-26 08:27:56.461216+00:00","record_version_id":"04a224592819478ed0164159f16c37bfd914dc04fc63b6273666771e4f4cf0b5","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-741602fbc6252c232a0b9e6bc1a9ae3101625f5a","semester":"1262","observed_at":"2025-06-30 22:49:32.522034+00:00","record_version_id":"31f646925a301cfbc562995add69c0b4a04b170bbc1413c05db1b62759663bee","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-7774f45558276ec29bf626e58fffb4a27bdbb2a9","semester":"1264","observed_at":"2025-11-01 11:49:36.359151+00:00","record_version_id":"0b095f7f157b8a037a4fd486403949c6cc62d6607afbb36dc04815f368ebc2fa","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-7ab7c5e783fc8ebef8b8ee8cea019ee37a72ce74","semester":"1262","observed_at":"2025-09-28 04:58:07.340658+00:00","record_version_id":"1c3b302b9899f4658ca84a90511f05d163c683841f572789df0f7eb0699cb863","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-7b2f22d83ea05055ab90dcb77dc802382cccc6f7","semester":"1262","observed_at":"2025-05-21 17:56:46.096741+00:00","record_version_id":"af9ccda69b951ddc8102c6fe05d15726bc572251896d90bb628e563330f73b98","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-7ca1175502be18eb51f7b016818a884a43fd4ebb","semester":"1262","observed_at":"2025-07-29 06:28:23.644795+00:00","record_version_id":"3ec8b3dbed50c41b989d23313f5cbd4861f463d497fd8aadc29dc35ea88e590e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-7d8cee5e42602ad9ba5dc0322085af2fa0dffaac","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"c67d68b7ae81e4b37264dbe134f809f28e6af4cfe4bc9ff63a07e0a4ddc18a31","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-81a0d6a7f668c98c59bd05fa988aa079c5ad1f68","semester":"1262","observed_at":"2025-05-31 07:49:50.419452+00:00","record_version_id":"4c8bbf7d6aa2528c7ada81b8110a410140f93491da95c1b0f188f1bdbc85bfb4","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-82f31c08c746a214872494cde6ecaeb9330441b4","semester":"1262","observed_at":"2025-06-17 21:26:08.547156+00:00","record_version_id":"b9ead40cafbf6b660cba83ba0e4bf35a7df21dacf1c6147310ce51dbbad6ff2e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-84c248343c5a99ab42c5616c594812a5e3e31cbb","semester":"1262","observed_at":"2025-07-04 06:00:07.487827+00:00","record_version_id":"6d0b0bf0d4c6308b08479b7dea273cc3f909a753f5d283f2c73728c93751ca9a","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-86334e7275e315853287e8580c35456c68df800b","semester":"1262","observed_at":"2025-05-22 06:53:03.336354+00:00","record_version_id":"1890bb42fdbf41d7e93bcd324642bf8be9c7c198af2a75fd54f53c0b1e5e9ed9","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-8686dc1664f93a6c05f50321410961b39b12f91b","semester":"1262","observed_at":"2025-05-28 10:17:41.595894+00:00","record_version_id":"63f962d97da358a19622d2ce50716df31396809d2b339c4274f833dfddb78fe6","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-86d941366886c9a14a2581c04e20d0bdd25e1b02","semester":"1262","observed_at":"2025-08-31 04:54:14.656039+00:00","record_version_id":"747d64c41f9c7538c89261b31a4feb058e757ad2e8e22674897b09560d5ab160","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-8ba1d2e6cfbb1525b4f9f769ec164fb6ad0f237a","semester":"1262","observed_at":"2025-06-02 05:22:45.010398+00:00","record_version_id":"d5f2e5f199081147374e8178d47a70ebd5838d42f9d6cb549aacc80ca292a6d3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-90e5aa456689a3b222016c05c319bbcd0bddd453","semester":"1262","observed_at":"2025-05-25 02:00:10.037905+00:00","record_version_id":"ac230b5f8dd882f989c4ed5d4d3d09d31c9aab96f64310718096939891636a07","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-92d960aa7e4cd6e4c9ac8b2e232092904038e9e4","semester":"1262","observed_at":"2025-06-08 01:50:46.451351+00:00","record_version_id":"8510ab2c6fcce8b6ea2bdecefde591dc629370ca915015acd775140602c620c3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-94002ae588a8f71eca6d64105f2e603e8587293b","semester":"1262","observed_at":"2025-05-21 09:01:16.021508+00:00","record_version_id":"6d090ca996327da2bb9d9c43ee244d7f6b04306c308e2ae337924af638eac220","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-9dd575e013c5c6e000ab3ad2d1288cc1dd9c96dc","semester":"1264","observed_at":"2025-12-21 04:47:46.589081+00:00","record_version_id":"6844bb6958c2067068eb84aaba30b645a0ce994b60ac54d4b68cee954b5efce9","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-a1ea26ed78cbd6e94bc3221e50a6ed9b6bf43871","semester":"1262","observed_at":"2025-05-25 09:16:55.180581+00:00","record_version_id":"3ad152cceb70efd165edb928ce7774d37d0bfab3bca7a2246c2678dec40e9a22","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-a76a3505853d5ea9c13bb98472b87361d469e2ee","semester":"1262","observed_at":"2025-05-28 18:03:41.793846+00:00","record_version_id":"58db1ffa27bd4f1d96146b14c236aa2e4f3b9859bf1caa643c815f3e0e816274","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-b285d591f6acf3aa1910e02edc297664db86eb8c","semester":"1262","observed_at":"2025-06-10 22:48:22.460295+00:00","record_version_id":"70e42232736fc2a5bbc6c745e5bd0c63e98e319b72bca9f351b8981b0d0b992e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-b79af756e4f00ba98231feb859ed8e98239eb811","semester":"1262","observed_at":"2025-05-22 02:47:56.931581+00:00","record_version_id":"aa3b21f659447519e9745683f3e8d27aa2a5dff3ee1872a0c3b2e4b895094a54","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-b89e05b94730c6471439082d9279c0a834a4aeec","semester":"1262","observed_at":"2025-08-26 20:25:42.325239+00:00","record_version_id":"1e58bfecb00f619943eba40677b5a33fdd1caa3a2100a04312f66de30f2299ee","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-b9279a12d1f2688df9e556183c94d41a89e431dc","semester":"1262","observed_at":"2025-07-06 01:49:47.203835+00:00","record_version_id":"f9c5ccda53371246758020ba904cd011bcb5b24df3baf54addc5eb5869e5a3d3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-bbdc905e96cc681a5e9a8b02c795b682206e36d1","semester":"1262","observed_at":"2025-06-25 08:02:45.445730+00:00","record_version_id":"2c1e9f0195572f2cef2e9c299f3e995ba1746f89a2ed25831eca748762763af7","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-bde225b5243a13d81827aa173e39c78a652b54a0","semester":"1262","observed_at":"2025-05-23 07:22:33.219345+00:00","record_version_id":"4af84b1b5e80b2d91dfaec75e4bcc72ac44520dd779b34bd23420c43565b8dad","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-c1fac4cbfde737f4f4ac02cdf15e6f5a9b5b676d","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"c67d68b7ae81e4b37264dbe134f809f28e6af4cfe4bc9ff63a07e0a4ddc18a31","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-c6b62be45f8a13cba109ef2a7741b9cd9a6b8272","semester":"1262","observed_at":"2025-08-24 08:48:09.035112+00:00","record_version_id":"bb630fd8b22c93c12bbaac53288bfc46fab6d5858e673de13ae23a075d1fefc4","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-cc83f62cb6db61f39320916d819ad48ce55cd96d","semester":"1262","observed_at":"2025-05-22 00:45:35.735230+00:00","record_version_id":"2b061a5b1e6ee5d1da1ba4c57bb66ef9368463d71ecdc52a233e356c26383f1c","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-d33818a01b6b4c5e2902e704da6e5b713742d4dc","semester":"1262","observed_at":"2025-10-13 10:46:24.251475+00:00","record_version_id":"11cd3204e96e6cb91c948ebf9373328ec1feeb892b07fe9bc5166cc71ac71a63","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-d3c17db9832d3064916046caf891dd23f10b1bb9","semester":"1262","observed_at":"2025-08-26 11:30:42.288639+00:00","record_version_id":"0cfb2a4c1ff6ba37236e063436cdcd0006c01e85f42e315ccaafd697d905ac38","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-d4ee226dc44268e9b6767fb9f5f20343322f494b","semester":"1262","observed_at":"2025-06-15 01:52:23.911697+00:00","record_version_id":"13d38932cf642c783b76a664ed0e0f72537b95dd20ec4f2c4c6b494cf3a7c8a6","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-d8f9fc7f136e2033556d9d65bbdbdf33425dbdc9","semester":"1262","observed_at":"2025-05-28 16:48:12.400438+00:00","record_version_id":"ce2c15c4601e8c26489dddfa8f2e0cbafe43ac0f441c65e8059b9f3366b5c2a8","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-dbbc9739c616c3846b2e796e00a36fa41225f7d8","semester":"1262","observed_at":"2025-06-01 17:47:19.325144+00:00","record_version_id":"05714c2fb77219d4f03d34eadae876aaf1ce7ef2325e33b917bee8be701aa40e","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-dbe5f2d24b48c3177297a3d69c553cc9d1194bac","semester":"1262","observed_at":"2025-09-14 05:00:27.366070+00:00","record_version_id":"41f24a4111609a9618bfdadccd3eb167e329b555f435b00f36c669dce57241fa","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-dd357dc2758e9e282c30988a527ce37de92593b9","semester":"1264","observed_at":"2025-10-19 01:39:41.951404+00:00","record_version_id":"ad06978e3f51e67183aedd7d8776fe6710569780f1d37184ea1e80809df1778b","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-de74de559e409a3fe668685e28043b888d2e6841","semester":"1262","observed_at":"2025-06-27 07:38:50.882897+00:00","record_version_id":"56f8c93abafb4c5453ecb4b6edad586fbc21eec4476408ce82bfa8b0008f73a7","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-deca7188cf536ade3203cd88b52a45e92a059617","semester":"1262","observed_at":"2025-06-27 00:37:46.087071+00:00","record_version_id":"052cbcf263ff2b2da73941cc08f63ffefc4a35a2bfa830a059e6ea5f149f72fa","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-df60fa9ac3931c5612b0fa641b7a6f5fbec86fab","semester":"1262","observed_at":"2025-05-24 06:36:37.554678+00:00","record_version_id":"59ee310a3c96a05e711bdc27d4d4c24399d5f0396310f88111f7b686b4ea7515","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-e339da2d849aaf8bb4dceca07a84728af23cf755","semester":"1262","observed_at":"2025-07-23 08:49:22.748925+00:00","record_version_id":"af4b232e193091b878f52877642c05afffa2b31abff61489b1641ffd4211b420","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-e934b1784835f5d36ae9b7ef0992b11e72c39142","semester":"1262","observed_at":"2025-06-01 06:21:25.219533+00:00","record_version_id":"6170ab16d697ad5a02e4d2b784295899ff27a63efbb0d99595df22aa418ea431","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-ef471690c082448deebd2687eab84b0b78813c36","semester":"1262","observed_at":"2025-06-29 01:47:56.317645+00:00","record_version_id":"0cfa0454cc4a15e600b3f4ee6e553c91b969cb194149da139a320ef9e61cccc3","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-efc4e8e2cd7c3f68e059a308990c00c77c7611eb","semester":"1264","observed_at":"2025-10-16 05:48:13.935141+00:00","record_version_id":"ccea5b30793be60faa7feb2a9453c2889fd05c77a43dd9489347bb59a3810422","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"},{"run_id":"legacy-f18b7749725097d41f69c60779ff38cf073b93b3","semester":"1262","observed_at":"2025-05-21 19:52:03.259353+00:00","record_version_id":"981b8f71d4bbc4293c29bf3e441dd7a4095bd21f5ab95f7861131e6aafee3e1d","course_id":"MEDICINE 880","course_uid":"course_0cab0566ed712f62a78e3be1","catalog_version_id":"23bfa519d2dcc8717a808c750bff89331eeb478639c96bbe6f9e8666b6baa695","course_number":880,"subjects":["MEDICINE"],"title":"THE BODY ELECTRIC: INTERSECTION OF CELLULAR ELECTROPHYSIOLOGY WITH CLINICAL ELECTROCARDIOGRAPHY","description":"Mapping of cellular and conduction perturbations to observed changes on the surface ECG recording for inherited arrhythmia syndromes (e.g., long QT syndrome, Brugada syndrome), drug toxicities (Class IC and III antiarrhythmics, digoxin excess), cardiac arrest, electrolyte disturbances, and metabolic disturbances; Selection of appropriate therapies, including antiarrhythmics and device therapies, and how they affect cardiac electrophysiology and the clinical ECG.","requirements_text":"MED SC-M 810,811,812, and813"}]